Hundreds of genes have been implicated in autism spectrum disorders (ASDs). In genetically heterogeneous conditions, large families with multiple affected individuals provide strong evidence implicating a rare variant, and replication of the same variant in multiple families is unusual. We previously published linkage analyses and follow-up exome sequencing in seven large families with ASDs, implicating 14 rare exome variants. These included rs200195897, which was transmitted to four affected individuals in one family. We attempted replication of those variants in the MSSNG database. MSSNG is a unique resource for replication of ASD risk loci, containing whole genome sequence (WGS) on thousands of individuals diagnosed with ASDs and family members. For each exome variant, we obtained all carriers and their relatives in MSSNG, using a TDT test to quantify evidence for transmission and association. We replicated the transmission of rs200195897 to four affected individuals in three additional families. rs200195897 was also present in three singleton affected individuals, and no unaffected individuals other than transmitting parents. We identified two additional rare variants (rs566472488 and rs185038034) transmitted with rs200195897 on 1p36.33. Sanger sequencing confirmed the presence of these variants in the original family segregating rs200195897. To our knowledge, this is the first example of a rare haplotype being transmitted with ASD in multiple families. The candidate risk variants include a missense mutation in SAMD11, an intronic variant in NOC2L, and a regulatory region variant close to both genes. NOC2L is a transcription repressor, and several genes involved in transcription regulation have been previously associated with ASDs.
Introduction
Autism spectrum disorders (ASDs) are behaviorally defined neurodevelopmental disorders. They are characterized by deficits in communication and social interactions and by the presence of repetitive behaviors or restricted interests (American Psychiatric Association 2013). Individuals with ASD also have elevated risk of epilepsy (Bolton et al. 2011) and intellectual disability (Dykens and Lense 2011) compared to the general population. Including the most mildly affected individuals, ASDs affect 1 in 59 children at 8 years of age (Baio et al. 2018) . Individuals with ASDs require significant support in childhood and often into adulthood, including special education, occupational therapy, and supportive living accommodation (Buescher et al. 2014) . The cost of these supports over a lifetime for an individual with an ASD without intellectual disability was recently estimated at US$1.4 million (Buescher et al. 2014) .
ASDs are substantially heritable, with concordance rates between monozygotic twins of 50-90%, and between Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0043 9-018-1939-3) contains supplementary material, which is available to authorized users.
siblings of 3-26% (Berg and Geschwind 2012) . The risk of ASD to subsequent siblings of children with autism is estimated at 18.7% (Ozonoff et al. 2011) . Unfortunately, this relatively high heritability is not the result of a simple genetic architecture involving a small number of genes. Because of the complex biology underpinning the development of the human brain, it is likely that there are many genes that can be involved in the development of ASD. The number of genes estimated to be involved in ASDs ranges from hundreds (O'Roak et al. 2012; Sanders et al. 2011) to as high as a thousand . Studies using data sets composed of singleton cases (Neale et al. 2012; O'Roak et al. 2012; Sanders et al. 2012) yield long lists of genes where potentially deleterious changes (including single nucleotide variation, structural variation, and copy number variation) are observed in individuals with ASD. Without large and well-matched control populations, it is difficult to identify which are false positives, and which are genuine risk variants (Gratten et al. 2013) . Nonetheless, these findings have allowed description of protein networks and pathways that are likely related to ASDs (De Rubeis et al. 2014; Krumm et al. 2014; O'Roak et al. 2012) . Three categories of genes that are consistently implicated in autism include those that (1) affect synapse formation (Gilman et al. 2011 ) and function (Krumm et al. 2014) , or are involved in (2) transcriptional regulation (Ben-David and Shifman 2013), or (3) chromatin remodeling (Krumm et al. 2014) .
In other highly genetically heterogeneous traits, analysis of large extended families with multiple affected subjects has been instrumental in the identification of risk genes [e.g. retinitis pigmentosa (Kozma et al. 2005; Villanueva et al. 2014; Yu et al. 2016) ]. This approach provides solid evidence for single genes in such a disorder. In ASDs, identification of large families is difficult, and it is unusual to find affected relatives more distantly related than siblings. This may be due to reduced reproductive fitness of individuals with ASD (Power et al. 2013) , reduced penetrance or variable expressivity of genotypes containing ASD risk alleles, or the challenges inherent in measuring a behavioral phenotype. In nuclear families with two or more children affected by ASD, unaffected relatives often show the broader autism phenotype (BAP)-that is, they show some characteristics associated with ASD but not enough to merit an ASD diagnosis (Bernier et al. 2012; Piven et al. 1997 ). This phenotypic variation may be the result of incomplete penetrance or variable expressivity of ASD alleles. Rare variants that segregate to individuals with ASD and BAP within a family are excellent candidates for autism risk variants, and identify autism risk genes (Chapman et al. 2015; Cukier et al. 2014) . Because of the extreme genetic heterogeneity underlying ASDs, finding two families in which the same gene is implicated is rare, and typically involves different variants within the gene (Cukier et al. 2014) . Finding two unrelated families in which the same rare variant or haplotype segregates with ASD is exceedingly rare. In a resequencing study of CHD8 (a strongly supported ASD risk gene) in 3730 children with developmental delay or ASD, 17 rare potentially disruptive single nucleotide variants were identified, and none were carried by more than one affected individual (Bernier et al. 2014) .
In 2015, we published a linkage analysis of ASD in seven extended families, each with three or more affected individuals (Chapman et al. 2015) . We performed linkage analyses using dense SNP panels and identified multiple regions of interest within each family. Whole exome sequence (WES) was available for select individuals in each family, resulting in a list of 28 candidate exome variants (Chapman et al. 2015 , Table 4 ). At that time, no other ASD datasets were publicly available in which to attempt replication of our findings.
Here, by interrogation of the MSSNG database (Yuen et al. 2017) , we provide replication of some of our earlier findings. The MSSNG database contains whole genome sequence (WGS) on thousands of individuals diagnosed with ASD and their immediate family members. Remarkably, in this database, we found the transmission of one candidate exome variant identified in our earlier study (Chapman et al. 2015) , to multiple ASD individuals in multiple families. Furthermore, we identified two other rare variants transmitted on the same background haplotype, which in turn implicate two genes. Satisfyingly, one of these genes is a transcription repressor, and thus is a good candidate to be the cause of ASD in the families identified.
Methods

MSSNG database
The version of the MSSNG database (https ://resea rch.mss. ng/ db5, October 20, 2017) (Yuen et al. 2017 ) that we used contains WGS for 7191 people (3427 with ASD and 3764 without), representing families ascertained in nine different studies. Platforms used for WGS include Complete Genomics, Illumina HiSeq 2000 and HiSeq X. Detailed phenotypic information is available for most individuals with ASD, although the depth of phenotyping and the exact measures used vary extensively across individuals in the database. Individuals from 2757 families are represented, most of whom are in trios (one affected child, two parents) or quads (two affected children, two parents). Details of ascertainment, phenotyping, and sequencing have been published separately (Yuen et al. 2017) .
TDT analysis of candidate exome variants
Our original list of candidate variants (Chapman et al. 2015) was based on filtering for alternate allele frequency < 5% in 1000 Genomes Europeans (Altshuler et al. 2015) , because the vast majority of our families were of European descent. Here we tightened our frequency requirement to < 1% in the ExAC database (Lek et al. 2016) , further restricting the number of variants to consider to be 14. For each variant, we identified all carriers in MSSNG, then extracted available genotype and phenotype (affected/unaffected) information for them and all related individuals. We examined carrier parents who were members of trios (parents and one affected child) or nuclear families (parents and two or more affected children) and tabulated the number of transmissions (T) and non-transmissions (U) of the alternate allele from carrier parents to affected children. A standard TDT test (Spielman et al. 1993 ) then offers a test of the null hypothesis that the variant is neither linked to nor associated with ASD. Because many of the variants are exceedingly rare and ASD is so genetically heterogeneous, we expect to see few copies of the variants and, therefore, power is not large, even using the large MSSNG database. Therefore, we did not require strictly significant p values, but rather used them to prioritize variants for further consideration. When studying rare variants and complex disease, rigorously assessing significance is difficult, and correcting for multiple testing compromises power. Identification of three families segregating a rare variant is considered strong evidence of causality (Brunham and Hayden 2013) . Only 1 of the 14 variants under consideration showed evidence of linkage and/or association with ASD, and subsequent analyses focused on this candidate exome variant alone.
Identification of rare cosegregating whole genome variants
Because the candidate exome variant was ascertained using WES in local family AU071 (Chapman et al. 2015) , it is possible that the cosegregation with ASD observed in MSSNG and AU071 actually reflects a risk variant outside of the exome on the underlying haplotype. If this is the case, the exome variant is merely tagging a risk haplotype rather than itself being a risk variant. The availability of WGS in MSSNG allows us to pursue this question. Most affected individuals in MSSNG are part of a trio design, where both the individual and their parents have WGS. This allows unambiguous determination of the haplotype transmitted from the parent carrying the candidate exome variant to the affected child at all locations where only one parent is heterozygous (likely when the alternate allele is either very common or very rare). We restricted consideration to cosegregating variants that were rare (alternate allele frequency in 1000 Genomes Europeans < 1%).
TDT testing of rare cosegregating whole genome variants
Variants that cosegregate with the candidate exome variant are not necessarily associated with ASD, because they may also appear independently. To test for linkage and association with ASD, we extracted carriers of each rare cosegregating variant and their family members from MSSNG and performed the TDT test, as previously described for the exome variants.
Annotation of candidate risk variants
The candidate exome variant and rare cosegregating variants not ruled out by the TDT test were annotated using Variant Effect Predictor and Ensembl (Zerbino et al. 2018) for functional annotation and gnomAD (Lek et al. 2016) for allele frequencies. GERP++ (Davydov et al. 2010 ) and phastCons scores (Felsenstein and Churchill 1996) were also obtained, using CADD v1.3 (Kircher et al. 2014 ). Tissuespecific protein expression levels were obtained from Protein Atlas (Uhlen et al. 2015) .
Sanger sequencing of candidate risk variants
Given the expense of WGS, we used Sanger sequencing to provide genotypes in individuals in local family AU071 for the small number of candidate risk variants. Genomic DNA was PCR-amplified using customized primers designed by the online tool Primer3Plus (Untergasser et al. 2007 ) with HotStartTaq Plus DNA Polymerase (QIAGEN) with annealing temperatures of 58 °C. GenScript Biotech (Piscataway, NJ) performed Sanger sequencing. Biosamples are not available for individuals in the MSSNG database, so there was no opportunity to validate variants in them. The study involving AU071 was approved by the University of Washington Institutional Review Board, and informed consent was obtained from all participants or their parents. Table 1 shows the results of analyses using the MSSNG data and the 14 previously identified exome variants. All but 1 of the 14 are observed in the MSSNG database, but only 1 stands out as having a transmission pattern consistent with being a risk variant for ASD. Variant rs200195897 (1:877,523 C→G, GRCh37) is a missense variant in
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SAMD11 and is present in 10 copies in MSSNG. Table 2 describes the MSSNG families in which this variant occurs. Figure 1a shows our family AU071, and Fig. 1b depicts the MSSNG families. In the MSSNG families, seven of the ten copies are involved in transmissions to four affected children. This is scored as four transmissions and zero nontransmission (exact TDT p value = 0.0625). Three copies of the variant appear in singleton affected individuals whose parents are not sequenced, and one of these also has an affected half-sibling who does not carry the variant.
Identification of rare variants cosegregating with rs200195897 in MSSNG
Because rs200195897 was ascertained using WES in AU071, it is possible that cosegregation of this variant with ASD reflects a risk variant outside of the exome, on the underlying haplotype. If this is the case, rs200196897 merely tags a risk haplotype, rather than itself being a risk variant. The availability of WGS in MSSNG yields an exhaustive list of rare variants cosegregating with rs200195897, on all four transmitted haplotypes (see Table 3 ). One copy of each of the five cosegregating variants is also found in each of the three singletons, which is consistent with the singletons also carrying the same haplotype.
TDT testing of cosegregating variants
The rare variants that cosegregate with rs200195897 are not necessarily associated with ASD because they may also appear independently of rs200195897. To test for linkage and association with ASD, we performed the TDT test on genotype data from all carriers of each of the five cosegregating variants and their family members in MSSNG. Table 3 shows that two of the five are present in many additional individuals and are not associated with ASD. The remaining three cosegregating variants are present in exactly the same individuals as rs200195897, and no additional individuals, and, therefore, have the same borderline significant p value. Thus, we are left with a total of four SNPs that are candidate risk variants for ASD in these families, marked with a superscript in Table 3 . 
Sanger sequencing of candidate risk variants in AU071
By Sanger sequencing in AU071 we confirmed (1) the genotypes of the exome variant rs200195897 as indicated in Fig. 1a , and (2) the presence of rs566472488 and rs185038034 alternate alleles in all carriers of rs200195897, and no one else. This confirms that the background haplotype containing the rs200195897 alternate allele is shared amongst AU071 and all MSSNG families. rs544092417 was not observed in AU071. The most likely explanation is that this represents sequencing artifacts in the original WES data and the WGS data reported in MSSNG, as the variant is next to a LINE element (Kent et al. 2002; Rosenbloom et al. 2013) , and this may interfere with accurate alignment. rs200195897 is the variant whose predicted consequences are the most severe. It is a missense variant in SAMD11, and also part of a promoter binding site in regulatory region ENSR00000000109, which may influence transcription of NOC2L, a gene about 2 kb distant. rs200195897 is in a conserved element, as identified by GERP++ (GerpRS = 789.8 p = 7 × 10 −71 ). Additionally, phastCons scores indicate high probabilities of conservation within vertebrates (0.998) and within the subset of mammals (0.955).
Annotation of candidate risk variants
Phenotypes of affected carriers
Examination of phenotype data suggests some common characteristics of carriers. Tables 5 and 6 summarize phenotypes relating to language delay [age at first word and phrase, Autism Diagnostic Interview-Revised (ADI-R, Rutter et al. 2003) ], IQ [Wechsler Intelligence Scales (Wechsler 1981 , 1989 , 1992 , Peabody Picture Vocabulary Test (Dunn and Dunn 2007) , Stanford-Binet Intelligence Scales 5 (Roid 2005) ], autism diagnosis [ADI-R , Autism Diagnostic Observation Schedule (ADOS, Lord et al. 1999 Lord et al. , 2000 Lord et al. , 2003 ], and social functioning [Social Responsiveness Scale-2 (SRS2, Constantino 2012) ] in all available affected carriers of the candidate risk variants. AU071-05 does not meet ADOS criteria for an ASD diagnosis, but shows characteristics of BAP. The data in Table 5 indicate that there is no evidence of language delay, and (with one exception) individuals are of average or higher intelligence. Table 6 shows consistent impairments in social communication and interactions for most carriers. Online Resource 1 contains tables that summarize other available phenotypes, including adaptive measures [Vineland Adaptive Behavior Scales II (Sparrow et al. 2005) , Adaptive Behavior Assessment System II (Harrison and Oakland 2008) ] and measures of social functioning (SRS2-Constantino 2012). Because the individuals were recruited in different studies, there are few 
Discussion
We replicated the transmission of one candidate exome variant identified in our earlier study (Chapman et al. 2015) to multiple ASD individuals in multiple families in MSSNG. Non-replication of transmission of the other 13 variants has several possible explanations. First, four of the variants were simply too rare for meaningful testing in the MSSNG sample. Second, the original variants were identified by linkage analysis, using suggestive evidence of linkage because of limited family sizes, followed by filtering of WES variants based on both frequency and function. The lower threshold used for linkage evidence would be expected to introduce some false positives. A third possibility is that some of these exome variants are on a background haplotype where a nonexome variant increases ASD risk-such variants are invisible to exome sequencing. In addition to the observation of rs200195897 in MSSNG, we identified two other rare variants transmitted on the same background haplotype. The two genes near the variants are sterile-α-motif domain containing gene 11 (SAMD11) and a NOC2-like nucleolar-associated transcriptional repressor (NOC2L). SAMD11 is evolutionarily conserved from zebrafish to humans. It is expressed primarily in developing retinal photoreceptors and in the adult mouse pineal gland (Jin et al. 2013) , and shows very low levels of RNA transcript in human brain (Uhlen et al. 2015) . It is, therefore, not an obvious candidate gene for ASD although there are other genes containing a SAM domain that have been implicated in ASD [e.g. SHANK1-3 (Shi et al. 2017)] . NOC2L is ubiquitously expressed throughout embryonic development and adulthood (Hublitz et al. 2005) . It is expressed at high levels in Purkinje cells of the cerebellum, and medium levels in neuronal cells in both the hippocampus and the caudate nucleus (Uhlen et al. 2015) . Several genes that are involved in transcriptional regulation play a major role in ASD (De Rubeis et al. 2014) including CHD8, which is the biggest contributor of de-novo variation linked with ASD (Cotney et al. 2015) , and MECP2, which is responsible for Rett syndrome (Amir et al. 1999) . NOC2L is, therefore, an excellent candidate gene, and transmission of a promoter region variant in multiple families is suggestive of a role in ASD.
The evidence presented here implicates this haplotype on 1p36.33 in susceptibility to ASD. In light of the extreme genetic heterogeneity underlying ASD, replication of transmission in four distinct families provides a high degree of confidence in the validity of this finding. Functional studies are the natural next step to understand the importance and consequences of these variants. One approach would be to compare SAMD11 and NOC2L expression in neurons derived from carrier-specific induced pluripotent stem cells (Lin et al. 2011) (iPSCs) to that in iPSCs derived from noncarrier siblings. Another approach would be to generate knock-in mice carrying these variants (Singh et al. 2015) and evaluate the phenotypic consequences (Silverman et al. 2010) . Functional experiments such as these are beyond the scope of the current project, but are needed to determine which of the variants convey risk. In the meantime, SAMD11, NOC2L, and nearby regulatory regions should be considered as genomic regions where variants can increase the risk of ASD.
